Many DM drug metabolites are eliminated via the kidneys, such as biguanide, sulphonylureas, dipeptidylpeptidase-4 inhibitors, and SGLT-2 inhibitors, possibly burdening renal function [28]. Here, DPP4 is linked to diabetes mellitus.